1,060 filings
Page 23 of 53
10-KT
EYPT
EyePoint Pharmaceuticals Inc
18 Mar 19
Annual report (with FYE transition)
5:30pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
14 Mar 19
Results of Operations and Financial Condition
7:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
19 Feb 19
EyePoint Pharmaceuticals Secures Up to $60 Million Debt Facility
4:00pm
SC 13D/A
EYPT
EyePoint Pharmaceuticals Inc
13 Feb 19
EyePoint Pharmaceuticals, Inc.
2:36pm
5
Essex Woodlands IX, LLC
13 Feb 19
Annual statement of changes in insider ownership
2:31pm
4
David R Guyer
29 Jan 19
EyePoint Pharmaceuticals / DAVID R GUYER ownership change
4:08pm
3
EYPT
EyePoint Pharmaceuticals Inc
29 Jan 19
EyePoint Pharmaceuticals / DAVID R GUYER ownership change
4:02pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
29 Jan 19
EyePoint Pharmaceuticals Appoints David Guyer, M.D., to Board of Directors
4:02pm
424B5
EYPT
EyePoint Pharmaceuticals Inc
18 Jan 19
Prospectus supplement for primary offering
4:59pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
18 Jan 19
Entry into a Material Definitive Agreement
4:50pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
14 Jan 19
EyePoint Pharmaceuticals Provides 2019 Commercial Update
8:29am
8-K
EYPT
EyePoint Pharmaceuticals Inc
4 Jan 19
Other Events
4:06pm
4
EYPT
EyePoint Pharmaceuticals Inc
26 Dec 18
EyePoint Pharmaceuticals / Leonard S Ross ownership change
4:06pm
EFFECT
EYPT
EyePoint Pharmaceuticals Inc
12 Dec 18
Notice of effectiveness
12:15am
CORRESP
EYPT
EyePoint Pharmaceuticals Inc
10 Dec 18
Correspondence with SEC
12:00am
UPLOAD
EYPT
EyePoint Pharmaceuticals Inc
30 Nov 18
Letter from SEC
12:00am
S-3
EYPT
EyePoint Pharmaceuticals Inc
Shelf registration
28 Nov 18
5:18pm
4
EYPT
EyePoint Pharmaceuticals Inc
16 Nov 18
EyePoint Pharmaceuticals / MICHAEL W ROGERS ownership change
4:00pm
10-Q
2019 Q1
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
9 Nov 18
4:23pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
6 Nov 18
Highlights Recent Clinical and Operational Developments
7:20am